News & Perspective

May 01, 2012

May 01, 2012

NIH preparing tool to help labs cope with new DURC policy

(CIDRAP News) – Federal officials are working on guidance to help local institutions implement the government's new policy on the oversight of life-sciences dual-use research of concern (DURC), an official from the National Institutes of Health (NIH) said today.

Jul 29, 2011

Jul 29, 2011

Study: Antibody binds to all influenza A subtypes

(CIDRAP News) – A team of European researchers reported yesterday the discovery of a human monoclonal antibody that binds to all types of influenza A viruses, raising the prospect of a new flu treatment and improving the chances of developing a broadly protective or "universal" flu vaccine.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

May 29, 2007

May 29, 2007

Welsh officials announce four H7N2 flu cases, suspect human-to-human transmission

(CIDRAP News) - Four people in Wales and northwest England have tested positive for the low-pathogenic H7N2 avian influenza subtype found last week in chickens at a small farm in Wales, and local public health authorities suspect some degree of human-to-human transmission of the disease.

Oct 28, 2005

Oct 28, 2005

Chiron wins H5N1 vaccine contract; WHO says virus is changing

(CIDRAP News) – The US government has awarded Chiron Corp. a $62.5 million contract to make a vaccine for H5N1 avian influenza as part of efforts to prepare for a possible human flu pandemic.

Nov 17, 2004

Nov 17, 2004

Clinical trials of human H5N1 flu vaccine to start soon

(CIDRAP News) – Clinical trials of a vaccine designed to keep the H5N1 avian influenza virus from sparking a human flu pandemic will begin early in 2005, the head of the National Institute of Allergy and Infectious Diseases (NIAID) said this week.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»